Literature DB >> 10618616

Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C.

A Obermair1, M Geramou, F Gucer, U Denison, A H Graf, E Kapshammer, W Neunteufel, I Frech, A Kaider, C Kainz.   

Abstract

BACKGROUND: In several case reports, distension and irrigation of the uterine cavity during fluid hysteroscopy was suspected to cause tumor cell dissemination into the abdominal cavity in patients with endometrial carcinoma. It was the aim of this study to compare the incidence of positive peritoneal cytology in patients who underwent dilatation and curettage (D & C) with or without previous hysteroscopy.
METHODS: The authors conducted a multicentric, retrospective cohort analysis. One hundred thirteen consecutive patients with endometrial carcinoma treated between 1996 and 1997 were included. Endometrial carcinoma had to be limited to the inner half or less than the inner half of the myometrium (pathologic Stage IA,B). Positive peritoneal cytology was obtained during staging laparotomy. Patients underwent D & C either with or without prior diagnostic fluid hysteroscopy. No selection or randomization was applied to the two groups. Positive peritoneal cytology, defined as malignant or suspicious, was considered the primary statistical endpoint.
RESULTS: Peritoneal cytology was suspicious or positive in 10 of 113 patients (9%). The presence of suspicious or positive peritoneal cytology was associated with a history of hysteroscopy (P = 0.04) but not with myometrial invasion (P = 0.57), histologic subtype (P = 1.00) or grade (r = 0.16, P = 0.10), or the time between D & C and staging laparotomy (r = 0.04, P = 0.66).
CONCLUSIONS: Based on the limited extent of endometrial carcinoma in the current analysis, our data strongly suggest dissemination of endometrial carcinoma cells after fluid hysteroscopy. Determining whether a positive peritoneal cytology affects the prognoses of patients without further evidence of extrauterine disease will require longer follow-up. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10618616

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Does duration of hysteroscopy increase the risk of disease recurrence in patients with endometrial cancer? A multi-centre trial.

Authors:  Clemens Tempfer; Georg Froese; Bernd Buerkle; Stephan Polterauer; Christoph Grimm; Nicole Concin; Gerda Hofstetter; Monika Weigert; Martin K Oehler
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

2.  Can magnetic resonance spectroscopy differentiate endometrial cancer?

Authors:  Jie Zhang; Shifeng Cai; Changzhong Li; Xichao Sun; Xue Han; Chunrun Yang; Caixia Fu; Qingwei Liu; Yinghui Xin; Yuanyuan Zong
Journal:  Eur Radiol       Date:  2014-06-06       Impact factor: 5.315

3.  Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up.

Authors:  Pietro Cignini; Salvatore Giovanni Vitale; Antonio Simone Laganà; Antonio Biondi; Valentina Lucia La Rosa; Giuseppe Cutillo
Journal:  Updates Surg       Date:  2017-01-20

Review 4.  Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.

Authors:  Jeong-Yeol Park; Joo-Hyun Nam
Journal:  Oncologist       Date:  2015-02-11

5.  Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer.

Authors:  Marco Maccauro; Giovanni Lucignani; Gianluca Aliberti; Carlo Villano; Maria Rita Castellani; Eugenio Solima; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-30       Impact factor: 9.236

6.  Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations.

Authors:  Malcolm G Munro
Journal:  Perm J       Date:  2013-12-30

7.  Total laparoscopic hysterectomy versus total abdominal hysterectomy: cohort review of patients with uterine neoplasia.

Authors:  Katherine A O'Hanlan; Gloria Shining Huang; Anne-Caroline Garnier; Suzanne L Dibble; Mirjam L Reuland; Lisbeth Lopez; Rebecca L Pinto
Journal:  JSLS       Date:  2005 Jul-Sep       Impact factor: 2.172

8.  Hysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword.

Authors:  Jeong Yeol Park
Journal:  J Gynecol Oncol       Date:  2016-11-17       Impact factor: 4.401

9.  Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage.

Authors:  Andraz Dovnik; Bojana Crnobrnja; Branka Zegura; Iztok Takac; Maja Pakiz
Journal:  Radiol Oncol       Date:  2016-05-30       Impact factor: 2.991

10.  Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.

Authors:  Francesca Falcone; Giuseppe Laurelli; Simona Losito; Marilena Di Napoli; Vincenza Granata; Stefano Greggi
Journal:  J Gynecol Oncol       Date:  2016-08-08       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.